查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726231

基因組編輯市場規模、佔有率、趨勢分析報告：按技術、交付方式、應用、模式、最終用途、地區、細分市場預測，2025-2030 年

Genome Editing Market Size, Share & Trends Analysis Report By Technology, By Delivery Method, By Application, By Mode, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

基因組編輯市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球基因組編輯市場預計將在2030年達到250億美元，2025年至2030年的複合年成長率為16.1%。

基因組編輯技術的不斷進步、基因組學行業的資金籌措、遺傳疾病患病率的上升以及對改進治療和療法的需求是推動收益成長的關鍵因素。

基因組編輯技術的進步是推動市場收益成長的另一個因素。 CRISPR-Cas13、主要編輯和鹼基編輯等新的和先進的基因組編輯方法的進步使得最有效和最精確的基因編輯成為可能。這將導致基因組編輯方法在學術和醫學領域中得到更頻繁的應用。例如，2020年1月，ERS Genomics與New England Biolab合作開發並商業化CRISPR基因修飾工具和試劑。

隨著基因改造工具擴大應用於治療研究，越來越多的尖端療法正在進入臨床試驗。此外，利用人工智慧推進新基因改造系統的實施，對技術開發人員來說具有巨大的潛力。預計這將成為可預見的未來收益的一大優勢。研究界正在探索 CRISPR 等基因改造工具為各種慢性疾病提供快速篩檢解決方案的可能性。此類研究計畫很可能在未來幾年內使基因組編輯市場受益。

基因組編輯市場報告重點

  • 基因編輯技術 CRISPR 預計將成為生物技術領域發展最快的技術。 CRISPR 利用細菌的免疫系統來敲除基因或插入新的基因。
  • 基因組編輯技術的快速發展正在重塑治療格局，並推動旨在治療各種遺傳、血液、代謝和傳染病的臨床試驗的激增。
  • 體內基因組編輯正成為全球治療領域的變革力量。與傳統的體外方法不同，我們的體內方法允許直接在患者體內進行基因改造，從而無需複雜的細胞提取、操作和再灌注。
  • 2024 年，CRISPR/Cas9 領域佔據全球最大市場佔有率，為 44.36%。這是因為它具有高精度和高效率、多功能性和對不同實驗設計的適應性，以及成本效益和相對較低的相關成本。
  • 由於對基因編輯技術研發的投入不斷增加，北美基因組編輯市場預計將佔據全球市場的主導地位，到 2024 年將佔據 44.59% 的佔有率。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章 基因組編輯市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 基因組編輯市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章 基因組編輯市場：依技術進行估算與趨勢分析

  • 細分儀表板
  • 全球基因組編輯市場技術變遷分析
  • 全球基因組編輯市場規模及趨勢分析（依技術，2018-2030 年）
  • （CRISPR）/Cas9
  • TALEN/MegaTAL
  • ZFN
  • Meganucleases
  • 其他

第5章 基因組編輯市場：交付方式估算與趨勢分析

  • 細分儀表板
  • 全球基因組編輯市場交付方式變化分析
  • 2018-2030 年全球基因組編輯市場規模及趨勢分析（以交付方式）
  • 體外
  • 體內

第6章 基因組編輯市場：應用評估與趨勢分析

  • 細分儀表板
  • 全球基因組編輯市場應用變遷分析
  • 全球基因組編輯市場規模及趨勢分析（按應用，2018-2030）
  • 基因工程
    • 細胞株工程
    • 動物基因工程
    • 植物性因工程
    • 其他
  • 臨床應用
    • 診斷發展
    • 開發治療方法

第7章 基因組編輯市場：模式估計與趨勢分析

  • 細分儀表板
  • 全球基因組編輯市場模式變遷分析
  • 全球基因組編輯市場規模及趨勢分析（2018-2030）
  • 合約
  • 內部

第8章 基因組編輯市場：最終用途估計和趨勢分析

  • 細分儀表板
  • 全球基因組編輯市場的最終用途差異分析
  • 全球基因組編輯市場規模與趨勢分析（依最終用途，2018-2030 年）
  • 生物技術和製藥公司
  • 學術和政府研究機構
  • 合約研究組織

第9章 基因組編輯市場：區域、估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • Merck KGaA
    • Takara Bio Inc.
    • Revvity, Inc.
    • Danaher Corporation
    • GenScript
    • New England Biolabs
    • Charles River Laboratories
    • Eurofins Scientific
    • Lonza
    • Thermo Fisher Scientific, Inc.
Product Code: GVR-1-68038-399-7

Genome Editing Market Growth & Trends:

The global genome editing market size is expected to reach USD 25.00 billion in 2030 and is projected to grow at a CAGR of 16.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing advancements in genome editing technology, the growing funding & investments in the genomics industry, the increasing prevalence of genetic disorders, and the need for improved treatments and therapies are major factors driving revenue growth.

The evolution of genome editing technologies is another contributing factor to drive revenue growth in the market. Most effective and accurate gene editing is now possible through the enhancement of new and advanced genome editing methods including CRISPR-Cas13,prime editing, and base editing, amongst others. This creates genome editing methods used more often in academic and medical contexts. For instance, in January 2020, ERS Genomics and New England Biolab collaborated to develop and commercialize CRISPR gene modification tools & reagents.

The increasing application of gene-modification tools in therapeutic research has resulted in the rising number of advanced therapeutics entering clinical trials. Furthermore, the use of artificial intelligence to advance the implementation of novel gene modification systems exhibits great potential for the technology developer. This is anticipated to greatly favor revenue generation in the foreseeable future. Research communities are exploring the potential of gene-modification instruments such as CRISPR as a potential fast screening solution for various chronic diseases. Such research programs are likely to benefit the market for genome editing in the coming years.

Genome Editing Market Report Highlights:

  • Gene editing technology CRISPR is projected to be the burgeoning technology in biotechnology. CRISPR harnesses the bacterial immune system to either knock genes out or insert new genes.
  • The rapid advancement of genome editing technologies is reshaping the therapeutic landscape, driving a surge in clinical trials aimed at treating a wide range of genetic, hematologic, metabolic, and infectious diseases.
  • In vivo genome editing is emerging as a transformative force within the global therapeutic landscape. Unlike traditional ex vivo methods, in vivo approaches allow for direct gene modification inside the patient's body, eliminating the need for complex cell extraction, manipulation, and reinfusion.
  • The CRISPR/Cas9 segment held the largest market share of 44.36% of the global revenue in 2024. This can be attributed to high precision & efficiency, high versatility & adaptability to different experimental designs, and cost-effectiveness with relatively low expense associated
  • North America genome editing market dominated the global market and accounted for a 44.59% share in 2024, owing to the growing investments in the R&D of gene editing technologies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology Segment
    • 1.2.2. Delivery Method Segment
    • 1.2.3. Application Segment
    • 1.2.4. Mode Segment
    • 1.2.5. End-use Segment
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Genome Editing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Success in pre-clinical models drives demand for genome editing therapeutics
      • 3.2.1.2. Rising competition amongst market participants for business development
      • 3.2.1.3. Easy editing solutions for the development of therapeutics for a broad range of diseases
      • 3.2.1.4. Increasing demand for synthetic genes and genetically modified organisms
      • 3.2.1.5. Technological advancements in gene editing technologies
      • 3.2.1.6. Rising adoption in agricultural biotechnology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Challenges concerning clinical translation
      • 3.2.2.2. Regulatory, scientific, and ethical challenges regarding the use of genetically modified products
      • 3.2.2.3. Off-target effects of CRISPR technology
  • 3.3. Genome Editing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Genome Editing Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Genome Editing Market Technology Movement Analysis
  • 4.3. Global Genome Editing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. (CRISPR)/Cas9
    • 4.4.1. (CRISPR)/Cas9 market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. TALENs/MegaTALs
    • 4.5.1. TALENs/MegaTALs market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. ZFN
    • 4.6.1. ZFN market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Meganuclease
    • 4.7.1. Meganuclease market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Genome Editing Market: Delivery Method Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Genome Editing Market Delivery Method Movement Analysis
  • 5.3. Global Genome Editing Market Size & Trend Analysis, by Delivery Method, 2018 to 2030 (USD Million)
  • 5.4. Ex Vivo
    • 5.4.1. Ex vivo market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. In-Vivo
    • 5.5.1. In-vivo market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Genome Editing Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Genome Editing Market Application Movement Analysis
  • 6.3. Global Genome Editing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Genetic Engineering
    • 6.4.1. Genetic Engineering market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Cell Line Engineering
      • 6.4.2.1. Cell line engineering market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Animal Genetic Engineering
      • 6.4.3.1. Animal genetic engineering market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Plant Genetic Engineering
      • 6.4.4.1. Plant genetic engineering market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Clinical Applications
    • 6.5.1. Clinical applications market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Diagnostics Development
      • 6.5.2.1. Diagnostics development market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Therapy Development
      • 6.5.3.1. Therapy development market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Genome Editing Market: Mode Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Genome Editing Market Mode Movement Analysis
  • 7.3. Global Genome Editing Market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
  • 7.4. Contract
    • 7.4.1. Contract market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. In-house
    • 7.5.1. In-house market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Genome Editing Market: End-Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Genome Editing Market End-Use Movement Analysis
  • 8.3. Global Genome Editing Market Size & Trend Analysis, by End-Use, 2018 to 2030 (USD Million)
  • 8.4. Biotechnology and pharmaceutical companies
    • 8.4.1. Biotechnology and pharmaceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Academic and government research institutes
    • 8.5.1. Academic and government research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Contract research organizations
    • 8.6.1. Contract research organizations market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Genome Editing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. U.S.
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework
      • 9.4.1.3. Target disease prevalence
      • 9.4.1.4. Competitive scenario
      • 9.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. Canada
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Target disease prevalence
      • 9.4.2.4. Competitive scenario
      • 9.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. Mexico
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Target disease prevalence
      • 9.4.3.4. Competitive scenario
      • 9.4.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. UK
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework
      • 9.5.1.3. Target disease prevalence
      • 9.5.1.4. Competitive scenario
      • 9.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. Germany
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Target disease prevalence
      • 9.5.2.4. Competitive scenario
      • 9.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. France
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Target disease prevalence
      • 9.5.3.4. Competitive scenario
      • 9.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. Italy
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Target disease prevalence
      • 9.5.4.4. Competitive scenario
      • 9.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.5. Spain
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Target disease prevalence
      • 9.5.5.4. Competitive scenario
      • 9.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.6. Norway
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Target disease prevalence
      • 9.5.6.4. Competitive scenario
      • 9.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.7. Sweden
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Target disease prevalence
      • 9.5.7.3. Regulatory framework
      • 9.5.7.4. Competitive scenario
      • 9.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.8. Denmark
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Regulatory framework
      • 9.5.8.3. Target disease prevalence
      • 9.5.8.4. Competitive scenario
      • 9.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Japan
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework
      • 9.6.1.3. Target disease prevalence
      • 9.6.1.4. Competitive scenario
      • 9.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. China
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Target disease prevalence
      • 9.6.2.4. Competitive scenario
      • 9.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. India
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. Target disease prevalence
      • 9.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. Australia
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Target disease prevalence
      • 9.6.4.4. Competitive scenario
      • 9.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. South Korea
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Target disease prevalence
      • 9.6.5.4. Competitive scenario
      • 9.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. Thailand
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Target disease prevalence
      • 9.6.6.3. Regulatory framework
      • 9.6.6.4. Competitive scenario
      • 9.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Brazil
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework
      • 9.7.1.3. Target disease prevalence
      • 9.7.1.4. Competitive scenario
      • 9.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. Argentina
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Target disease prevalence
      • 9.7.2.4. Competitive scenario
      • 9.7.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. South Africa
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Target disease prevalence
      • 9.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. Saudi Arabia
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework
      • 9.8.2.3. Target disease prevalence
      • 9.8.2.4. Competitive scenario
      • 9.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.3. UAE
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework
      • 9.8.3.3. Target disease prevalence
      • 9.8.3.4. Competitive scenario
      • 9.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.4. Kuwait
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Regulatory framework
      • 9.8.4.3. Target disease prevalence
      • 9.8.4.4. Competitive scenario
      • 9.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Merck KGaA
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Takara Bio Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Revvity, Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Danaher Corporation
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. GenScript
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. New England Biolabs
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Charles River Laboratories
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Eurofins Scientific
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Lonza
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Thermo Fisher Scientific, Inc.
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global genome editing market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 5 Global genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 7 Global genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 8 Global genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 9 Global genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 North America genome editing market, by country, 2018 - 2030 (USD Million)
  • Table 11 North America genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 13 North America genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 14 North America genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 15 North America genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 16 North America genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 17 North America genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 U.S. genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 19 U.S. genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 20 U.S. genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 21 U.S. genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 22 U.S. genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 23 U.S. genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 24 U.S. genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Canada genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Canada genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 27 Canada genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 28 Canada genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 29 Canada genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 30 Canada genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 31 Canada genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Mexico genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Mexico genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 34 Mexico genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 35 Mexico genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 36 Mexico genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 37 Mexico genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 38 Mexico genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Europe genome editing market, by country, 2018 - 2030 (USD Million)
  • Table 40 Europe genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Europe genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 42 Europe genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 43 Europe genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 44 Europe genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 45 Europe genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 46 Europe genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Germany genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Germany genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 49 Germany genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 50 Germany genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 51 Germany genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 52 Germany genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 53 Germany genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 UK genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 55 UK genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 56 UK genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 57 UK genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 58 UK genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 59 UK genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 60 UK genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 France genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 62 France genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 63 France genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 64 France genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 65 France genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 66 France genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 67 France genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 68 Italy genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 69 Italy genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 70 Italy genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 71 Italy genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 72 Italy genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 73 Italy genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 74 Italy genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Spain genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 76 Spain genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 77 Spain genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 78 Spain genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 79 Spain genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 80 Spain genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 81 Spain genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Denmark genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Denmark genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 84 Denmark genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 85 Denmark genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 86 Denmark genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 87 Denmark genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 88 Denmark genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 Sweden genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Sweden genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 91 Sweden genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 92 Sweden genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 93 Sweden genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 94 Sweden genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 95 Sweden genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Norway genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 97 Norway genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 98 Norway genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 99 Norway genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 100 Norway genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 101 Norway genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 102 Norway genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 Asia Pacific genome editing market, by country, 2018 - 2030 (USD Million)
  • Table 104 Asia Pacific genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 105 Asia Pacific genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 106 Asia Pacific genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 107 Asia Pacific genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 108 Asia Pacific genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 109 Asia Pacific genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 110 Asia Pacific genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 China genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 112 China genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 113 China genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 114 China genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 115 China genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 116 China genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 117 China genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 118 Japan genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 119 Japan genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 120 Japan genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 121 Japan genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 122 Japan genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 123 Japan genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 124 Japan genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 125 India genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 126 India genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 127 India genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 128 India genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 129 India genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 130 India genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 131 India genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 132 South Korea genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 133 South Korea genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 134 South Korea genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 135 South Korea genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 136 South Korea genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 137 South Korea genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 138 South Korea genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 139 Australia genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 140 Australia genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 141 Australia genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 142 Australia genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 143 Australia genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 144 Australia genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 145 Australia genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 146 Thailand genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 147 Thailand genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 148 Thailand genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 149 Thailand genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 150 Thailand genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 151 Thailand genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 152 Thailand genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 153 Latin America genome editing market, by country, 2018 - 2030 (USD Million)
  • Table 154 Latin America genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 155 Latin America genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 156 Latin America genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 157 Latin America genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 158 Latin America genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 159 Latin America genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 160 Latin America genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 161 Brazil genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 162 Brazil genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 163 Brazil genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 164 Brazil genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 165 Brazil genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 166 Brazil genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 167 Brazil genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 168 Argentina genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 169 Argentina genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 170 Argentina genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 171 Argentina genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 172 Argentina genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 173 Argentina genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 174 Argentina genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 175 MEA genome editing market, by country, 2018 - 2030 (USD Million)
  • Table 176 MEA genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 177 MEA genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 178 MEA genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 179 MEA genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 180 MEA genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 181 MEA genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 182 MEA genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 183 South Africa genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 184 South Africa genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 185 South Africa genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 186 South Africa genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 187 South Africa genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 188 South Africa genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 189 South Africa genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 190 Saudi Arabia genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 191 Saudi Arabia genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 192 Saudi Arabia genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 193 Saudi Arabia genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 194 Saudi Arabia genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 195 Saudi Arabia genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 196 Saudi Arabia genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 197 UAE genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 198 UAE genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 199 UAE genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 200 UAE genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 201 UAE genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 202 UAE genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 203 UAE genome editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 204 Kuwait genome editing market, by technology, 2018 - 2030 (USD Million)
  • Table 205 Kuwait genome editing market, by delivery method, 2018 - 2030 (USD Million)
  • Table 206 Kuwait genome editing market, by application, 2018 - 2030 (USD Million)
  • Table 207 Kuwait genome editing market, for genetic engineering, by application, 2018 - 2030 (USD Million)
  • Table 208 Kuwait genome editing market, for clinical applications, by application, 2018 - 2030 (USD Million)
  • Table 209 Kuwait genome editing market, by mode, 2018 - 2030 (USD Million)
  • Table 210 Kuwait genome editing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Genome editing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Segment snapshot-3
  • Fig. 16 Competitive landscape snapshot
  • Fig. 17 Life science tools market value, 2024 (USD Billion)
  • Fig. 18 Market trends & outlook
  • Fig. 19 PESTEL analysis
  • Fig. 20 Porter's five forces analysis
  • Fig. 21 Genome editing market: Technology outlook key takeaways
  • Fig. 22 Genome editing market: Technology movement analysis
  • Fig. 23 CRISPR/Cas9 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 TALENs/MegaTALs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 ZFN market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Meganucleases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Genome editing market: Delivery method outlook key takeaways
  • Fig. 29 Genome editing market: Delivery method movement analysis
  • Fig. 30 Ex vivo market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 In vivo market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Genome editing market: Application outlook key takeaways
  • Fig. 33 Genome editing market: Application movement analysis
  • Fig. 34 Genetic engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Cell line engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Animal genetic engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Plant genetic engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Clinical applications market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Diagnostics development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Therapy development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Genome editing market: Mode outlook key takeaways
  • Fig. 43 Genome editing market: Mode movement analysis
  • Fig. 44 Contract market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 In-house market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Genome editing market: End-use outlook key takeaways
  • Fig. 47 Genome editing market: End-use movement analysis
  • Fig. 48 Biotechnology and pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Academic and government research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Regional marketplace outlook, 2024 & 2030 (USD Million)
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)